Monday, December 18, 2017

MSF drags Pfizer to court in India over patent on high-cost Gavi-funded vaccine

The medical humanitarian aid organisation Médecins Sans Frontières has taken the Indian Patent Office to court over a patent it recently granted to Pfizer for the pneumonia vaccine, Prevenar 13. MSF argues that the patent will stifle competition, blocking the development of cheaper, generic versions of the vaccine.


Leena Menghaney, Lawyer for MSF in India.
Photo: MSF Access Campaign

Development Today is a subscription-based online journal. To subscribe click here.

If you are already a subscriber to Development Today please log in.

Would you like to know more about Development Today? Click here.